An investigational cancer drug that starves tumors of their energy supply also shows evidence of improving whole body metabolism, leading to improved weight control, according to a new study in mice from researchers at Washington University School of Medicine in St. Louis.
An international study involving researchers at Washington University School of Medicine in St. Louis found that children up to age 18 with COVID-19 were at low risk for serious health problems stemming from such infections. The study was based on pediatric data analyzed up to June 2021, before the delta and omicron variants took hold.
Understanding how cells die is key to developing new treatments for many diseases, whether the goal is to make cancer cells die or keep healthy cells alive in the face of other illnesses, such as massive infections or strokes. Two new studies from Washington University School of Medicine in St. Louis have identified a previously […]
Researchers at Washington University School of Medicine in St. Louis have received three grants totaling more than $6.8 million to advance research on a novel imaging system to monitor uterine contractions.
Researchers at Washington University School of Medicine in St. Louis were awarded $575.8 million in funding from the National Institutes of Health (NIH) in federal fiscal year 2021, according to the School of Medicine’s 2021 State of the School Report, an increase of nearly $88 million over FFY2020. This is an all-time high for the […]
An immunotherapy harnessing the immune system’s “natural killer” cells has proven effective in treating acute myeloid leukemia (AML) in some adults whose cancers return. Now, researchers at Washington University School of Medicine in St. Louis have shown, in a small clinical trial, that the same natural killer cells also can help some children and young […]
David Alan Hunstad, MD, professor of pediatrics and of molecular microbiology at the School of Medicine, received a five-year $2 million grant from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) for research titled “Novel type 1 pilus receptors in pyelonephritis and recurrent UTI.”